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Chapter 3  
 
 
Synthesis of racemic and enantiopure  







This chapter describes the synthesis and chiral separation by preparative HPLC of a series 
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Synthesis of racemic and enantiomeric pure secondary phosphine oxides (SPO’s) 
  
3.1 Synthetic routes to secondary phosphine oxides (SPO’s) 
 
Generally, SPO’s are used as important intermediates for the preparation of phosphorus 
containing compounds, such as phosphines, tertiary phosphine oxides, phosphoric acids, 
etc.1 Due to their importance in synthetic phosphorus chemistry; several methods have 
been developed for the synthesis of this type of compounds. General methods to prepare 
SPO’s can be divided as follows: 
 
3.1.1 Symmetrical SPO’s 
 
(A) Grignard addition to phosphites 
 
Most symmetrical SPO’s can be prepared by this route. They can be easily made via 
Grignard reagents adding to (EtO)2PHO in THF solution at 0 oC.2 Most symmetrical alkyl 
or aryl SPO’s, such as Me2PHO (L3.1) and Ph2PHO (L3.2), could be prepared by this 














X = Cl, Br
+
 
R = Me, L3.1   R = Ph, L3.2 
 
Scheme 3.1 Synthesis of symmetrical SPO’s from Grignard reagents 
 
(B) Hydrolysis reactions; the hydrolysis of P-Cl compounds, phosphorus esters 3 or 
amides 4 
 
Symmetrical SPO’s can be made by this method. A few SPO’s like (t-Bu)2PHO, Ph2PHO 
(L3.2) and (n-C8H17)2PHO could be obtained directly from commercially available 
phosphorus chlorides (Scheme 3.2).5 Yields are normally quite good (79-96%) and the 
products are easy to purify as almost no side-products are formed. Some symmetrical 
SPO’s such as Me2PHO (L3.1) and Ph2PHO (L3.2) can also be prepared from the 
hydrolysis of the corresponding phosphorus esters or amides in 70-97% yields (Scheme 
3.2).  
R2PHOR2PX + H2O  
          X = Cl, OR’, NR’’2 
 
Scheme 3.2 The synthesis of SPO’s through hydrolysis 
 
Several aromatic compounds or Grignard reagents can react with PCl3 followed by 
hydrolysis to give SPO’s in moderate yields (Scheme 3.3). Some P-X compounds, such as 
(n-Bu)2PX (X=Br, Cl) can be made via direct halogenation of the secondary phosphine 
with Br2 or COCl2 in approx. 50% yield at –30 oC.6 After hydrolysis of the P-halogen 








          
R2PH Halogenation
R2PX R2PHOH2O  
  
Scheme 3.3 The preparation of P-X compounds and SPO’s 
 
(C) Direct oxidation of secondary phosphines 7
 
Secondary phosphines can be directly oxidized to secondary phosphine oxides (SPO’s) 
with oxygen or other oxidizing reagents. However, sometimes it is quite difficult to control 
the oxidation to stop at this stage and the reaction will proceed to phosphoric acids 
(Scheme 3.4). This oxidation is normally performed in 2-propanol as solvent. (n-Bu)2PHO 

















Secondary phosphines           SPO’s              Phosphoric acids 
 
Scheme 3.4 Oxidation of secondary phosphines  
 
(D) Reduction of phosphoric acid chlorides 2a,5a 
 
Via the reduction of phosphoric acid chlorides with LiAlH4 at 0 oC,  (n-C6H13)2PHO, 
(n-C8H17)2PHO and Ph2PHO (L3.2) were obtained via this method with reasonable yields 
(53-54%, Scheme 3.5). At more elevated temperatures, side-products, i. e. secondary 
phosphines are formed. Ph2POCl can also be reduced to Ph2PHO (L3.2) by Mg in THF or 





















Scheme 3.5 The synthesis of SPO’s by the reduction with LiAlH4
 
(E) Cleavage of tertiary phosphine oxides 10 
 
There are a few examples in which symmetrical SPO’s have been prepared via the cleavage 
of a P-C bond from a tertiary phosphine oxide (Scheme 3.6). With this method, Ph2PHO 
















Scheme 3.6 The cleavage of tertiary phosphine oxides 
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3.1.2 Unsymmetrical SPO’s 
 
In this thesis, a modified literature procedure reported by Haynes and co-workers 1b is used 
to prepare unsymmetrical SPO’s. In our experiments, Grignard reagents are added to a 
R’PCl2 solution at low temperature; the latter conditions are crucial to obtain the desired 
products. Unsymmetrical SPO’s are obtained via this procedure after hydrolysis of the 










                                                             R’ ≠ R’’ 
 
Scheme 3.7 General synthetic route to unsymmetrical SPO’s 
 
Our goal is to develop easier and more efficient methods to prepare symmetrical and 
unsymmetrical SPO’s and approaches to resolution to obtain the corresponding enantio- 
pure SPO’s. 
 
3.2 Preparation of symmetrical secondary phosphine oxides (SPO’s) 
 
Two symmetrical SPO’s were prepared by different routes. Me2PHO (L3.1) was obtained 








Scheme 3.8 The preparation of Me2PHO (L3.1) 
 
The reaction seems simple, but the reaction conditions need to be controlled carefully, 
otherwise a low yield (<10%) or even no desired product was obtained. The procedure is 
performed as follows: 3 eqs. of MeMgBr (2 M solution in Et2O) were added slowly to a 
(EtO)2PHO solution with ice-bath cooling to keep the temperature below 5 oC. Then the 
mixture was carefully hydrolyzed using an aq. K2CO3 solution at 0 oC. The product L3.1 
was obtained in 59% yield. 
Ph2PHO (L3.2) was prepared in high yield simply by the hydrolysis of commercially 
available Ph2PCl (section 3.1.1, route B) and purified by flash column chromatography 



















Scheme 3.9 Preparation of Ph2PHO (L3.2) 
 
In view of the high efficiency of BPE and DuPhos developed by Burk and co-workers as 
ligands for asymmetric hydrogenation, we wanted to explore the possibility to make a 






















Scheme 3.10 Cyclic C2-symmetric SPO’s 
 
Toward this type of SPO, several synthetic methods were examined.  
(1) A method similar to that for the synthesis of DuPhos11 (Scheme 3.11) 
Initially, the synthetic route for the racemic version of this type of compounds was 
explored. Thus a model compound trans racemic 3.1 with R = Me was selected as target. 
Analogues to the synthetic route of DuPhos and other analogues in the literature,  racemic 
trans cyclic phosphine 3.3 was prepared from racemic trans cyclic sulfite 3.2, which could 
be made from racemic trans 2,6-hexane diol by a 2-steps procedure developed by 
Sharpless and co-workers. Lithium was used to reduce the P-Ph bond and the resulting 
P-Li was protonated to provide trans cyclic phosphine 3.4. However, the oxidation of 3.4 
with O2, Br2, DMSO and H2O28 (30%) did not result in the desired product 3.1. The final 
product of these oxidations seems to be the corresponding phosphorus acid with 












racemic trans diol                           trans 3.2 
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                  trans  3.3                   trans 3.4                    trans 3.1 
 
Scheme 3.11 First approach to cyclic SPO 
 
Another route involved the addition of a MeLi solution to (TMS)3P12 followed by the 
reaction of the resulting lithium phosphine with racemic trans cyclic sulfate 3.2. However, 




P HMeLi + X
 
trans 3.2                              trans 3.4 
 
Scheme 3.12 TMS phosphine route to cyclic phosphine 3.4 
 
Also in the reaction of the bis-Grignard reagent derived from dibromide (B3.1) with 
ditheyl phosphite,13 no desired product 3.1 was formed. Presumably the reason for the sole 
formation of mono-substituted product of diethyl phosphite (observed in 31P NMR) and 















      racemic trans diol                                           B3.1                                                  3.1 
 
Scheme 3.13 Attempted Grignard addition to 3.1 
 
(2) Longer route 
As the above attempts to synthesize trans 3.1 failed, we investigate a somewhat longer 
route. Fiaud and co-workers14 reported a synthetic route to chiral phospholane, in which 














1. 10% Pd/C, H2
2.
(rac.) (rac.)
                               
R = Me, 3.5, 45%;                         R = Me, 3.7, 77%; 


























R = Ph, 3.9                                    L3.3 
 
Scheme 3.14 The synthesis of monodentate phosphine with L3.3 as intermediate 
 
The phosphoric amide 3.8 could be prepared in good yield and was then hydrolyzed to the 
corresponding trans racemic phosphoric acid followed by optical resolution with quinine 
to obtain enantiopure phosphoric acid L3.9. This was then converted to phosphoryl 
chloride followed by reduction with DIBAL-H to obtain enantiopure L3.3 (Scheme 3.14). 
However, we failed to reproduce this procedure to synthesize L3.3. In our hands the 
reduction of 3.9 with DIBAL-H failed. Using a similar procedure, its methyl analogue, 
trans phosphoric amide 3.7 was prepared in 55% yield (Scheme 3.14).  
With trans amides 3.7 and 3.8 in hand, we tried several procedures to complete the 
synthesis of 3.1 and L3.3.  
(1). First, we attempted their reduction on phosphorus atom of trans amides 3.7 and 3.8 to 
the phosphorus amides (P-N compounds) that subsequently should be quite easily 
hydrolyzed to the desired products (see section 3.1.1, method B). Several reducing agents, 
such as DIBAL-H, Red-Al, LiAlH4, and NaBH4 were investigated. Either no reaction 
occurred or the formation of desired products was not observed. Raney-Ni is known to 
have the ability to reduce the P=S(OH) bond to give SPO’s.15  However, Raney-Ni 
reduction of thiophosphoric amides 3.10 (trans, racemic), which can be easily made from 
3.8 (trans, racemic) with P2S5, only produced alkane 3.11. This might be due to the 









Tol Raney - Ni, H2
EtOH
 
               R = Ph, 3.8                 R = Ph, 3.10, 68%                     R = Ph, 3.11, 60% 
 
Scheme 3.15 Raney-Ni reduction of thiophosphoric amides 3.10 
 
With its methyl analogue 3.7, this reaction seemed to be successful. However, after 
hydrolysis, only 10% of desired product 3.1 was obtained. 
(2). A somewhat better alternative was the hydrolysis of 3.8 to the corresponding 
phosphoric acid 3.9, which was then converted into the phosphoryl chloride. Subsequent 
reduction with SmI216 
2
provided the product L3.3. However, the yield was low (approx. 
10%) with SmI  as reducing reagent. Optimization of the reaction conditions (the use of 
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dry reagents, lowering of the temperature to 0 C and long reaction time) did not improve 



















                     R = Ph, 3.8                   R = Ph, 3.9                        R = Ph, L3.3 
 
Scheme 3.16 Hydrolysis of 3.8 and reduction of its phosphoric acid chloride 
 
With trans amide 3.7 (R = Me), this procedure didn’t work at all. Other reducing reagents 
such as LiAlH4, Red-Al, Mg/I2, DIBAL-H, Li-PBPH (lithium perhydro-9b-boraphenalyl 
hydride, 0.5 M in THF) and LiB[CH3CH(CH3)2]3H were also tried, but no desired product 
could be isolated. On the contrary, with model compound Ph2POCl (from Ph2POOH and 
SO2Cl2) using a similar procedure, the reaction was quite successful and gave Ph2PHO 
(L3.2) in reasonable yield (45%).  
(3). Direct reduction to secondary phosphines followed by oxidation to final product L3.3. 
Besides general reducing reagents, silicon-containing reagents were tried. Fortunately, 
PhSiH317 or Si2 6
2
Cl 18 turned out to be quite efficient reducing agents for trans amide 3.8. 
Finally the C -symmetrical SPO trans L3.3 was made successfully by this method in 36% 










                       R = Ph, 3.8                          R = Ph, L3.3 
 
Scheme 3.17 The preparation of C2-symmetrical SPO L3.3 
 
3.3 Preparation of unsymmetrical secondary phosphine oxides (SPO’s) 
 
Several unsymmetrical SPO’s L3.4-L3.11, L3.14, L3.16 (Figure 3.1) have been prepared 
with the method described in section 3.1.2 in reasonable yields. The addition order of the 
Grignard reagents is crucial. The reactions are performed as follows: the Grignard reagent 














































                                         L3.3                         L3.14                         L3.16 
 
Figure 3.1 Structures of unsymmetrical SPO’s 
             
The phosphorus dichloride compounds used in these experiments are PhPCl2, t-BuPCl2, 
and (mesityl)PCl2 (3.12), respectively. The former two are commercially available, and 
3.12 can be made according to reported procedure starting from mesityl bromide and 











                                                                                             3.12 
Scheme 3.18 Synthesis of (mesityl)PCl2 3.12 
 
An attempt to synthesize 2-naphthyl-PCl2 (3.13) via a Friedel-Crafts reaction was not very 
successful.19 When naphthalene reacted with AlCl3 and PCl3, substitution at the α- and β- 
positions took place in almost equal amounts. It was not possible to separate the mixture of 
isomeric SPO’s L3.6 and L3.6a that were obtained after the Grignard addition and 
hydrolysis (Scheme 3.19). Through an alternative approach, ligand L3.6 was synthesized 
successfully via the addition of 2-naphthyl magnesium bromide to t-BuPCl2, followed by 
hydrolysis. Details will be described in the experimental part. 
 
 47























1). t-BuPCl2, -20oC, THF
14%
 
                                                                  L3.6 
 
Scheme 3.19 Attempt to the synthesis of 3.13 (2-naphthyl-PCl2) and L3.6 
 
Ligands L3.4, L3.5, L3.10, L3.14, L3.16 were prepared by adding t-BuMgCl, i-PrMgCl, 
2-naphthyl magnesium bromide, 2-methoxyphenyl magnesium bromide and the Grignard 
prepared from 3.1420 {[3-(diphenylphosphino)phenyl] magnesium bromide} to a PhPCl2 
solution, respectively. The products were then hydrolyzed and purified by vacuum 
distillation or flash column chromatography (SiO2, EtOAc) (Scheme 3.20, 3.21). The 
addition order in this procedure is crucial for getting the right products. When PhPCl2 was 
added to the corresponding Grignard reagents, double addition products, namely, tertiary 
phosphine oxides were found as the major products. One exception to this rule is the bulky 
t-BuMgCl; for this reagent the addition order was unimportant. L3.4 was synthesized in 
high yields without any problem. The fact that only single addition occurs is most probably 










L3.4, R = t-butyl, 86%; L3.5, R = i-propyl, 36%;  
L3.10, R = 2-naphthyl, 35%; L3.14, R = 2-methoxy-phenyl, 29% 
 
















3.14                                                 L3.16 





Ligand L3.9 was prepared using a similar procedure involving the addition of t-BuMgCl to 
a solution of 3.12 followed by hydrolysis. Ligands L3.6-L3.8, L3.11 were prepared using 
various Grignard reagents like 2-naphthyl; 2-methoxy-phenyl; 3, 5-dimethylphenyl and the 
Grignard prepared from 3.15 {[2-(diphenylphosphino)phenyl] magnesium bromide}, 
which were added to a t-BuPCl2 solution at –20 oC, followed by hydrolysis and purified by 
flash column chromatography (SiO2, EtOAc) (Scheme 3.22, 3.23). The addition order in 
this procedure is also crucial for getting the right products. If the addition order is reversed, 

















L3.6, R=2-naphthyl, 14%; L3.7, R=2-methoxy-phenyl, 68%; L3.8, R=3,5-dimethyl, 65%  
 
Scheme 3.22 General procedure for the synthesis of ligands L3.6-L3.8 
 
The successful preparation of intermediate 3.14 with n-BuLi and Ph2PCl (see scheme 3.21) 
prompted us to attempt a similar procedure for the synthesis of intermediate 3.15. However, 
the reaction failed to give any desired product. The phosphine 3.15 was synthesized 
successfully by making the Grignard reagent from 1,2-dibromobenzene, followed by the 


















                                                                         3.15                                                  L3.11 
 
Scheme 3.23 Synthetic route to ligand L3.11 
 
For comparison purposes, some other ligands were also synthesized in order to compare 
with the SPO’s in various catalytic reactions (see chapter 5 and 6). Phosphite ligand L3.12 
was prepared from (R,R)-Taddol and PCl3, followed by hydrolysis according to a literature 
procedure. Ligand L3.13 was prepared from R-Binol and Ph2PCl according to the 
literature (Figure 3.2).21  
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L 3.12                     L3.13                   L 3.15                L3.17            L3.18 
 
Figure 3.2 Non-SPO’s type ligands L3.12, L3.13, L3.15, L3.17, L3.18 
 
A sulfur analogue compound of SPO’s L3.17 was prepared from L3.4 with P2S5 in toluene 
in good yield according to a similar procedure reported in literature (Scheme 3.24).22 The 
disadvantage of this method is that enantiopure compounds cannot be used, as 
racemization occurs during the reaction and the final product is partially racemized (66% 
e.e. of the product was found with enantiopure starting material).22 Michalski and 
co-workers23 reported a 3-steps procedure by which enantiopure L3.17 could be prepared 
from (S)-(-)-L3.4 with full retention of configuration (Scheme 3.24). However, attempts to 
repeat this procedure with racemic and enantiopure L3.4 to prepare L3.17 failed. The last 
























EtOH 70%    
                   L3.4                                     3.16                                         L3.17 
                                                
Scheme 3.24 Attempts to the synthesis of L3.17 
 
Compounds L3.15, L3.18 were actually isolated as side-products in the attempts to 
synthesize pyridine-based ligands L3.20 and L3.21, respectively. We have found that 
pyridine can be successfully used as additive in Ir-catalyzed asymmetric imine 
hydrogenation using enantiopure SPO’s as ligands.24 It was found that in these reactions 
pyridine not only acts as a base but also as an extra ligand coordinating with the metal 
center (details see chapter 5). Pyridine-based SPO’s such as L3.19, L3.20 and L3.21 
(Figure 3.3), which can coordinate with metals as bidentate ligands, were therefore 































L3.19                                  L3.20                                   L3.21 
 
Figure 3.3 Structure of pyridine-based SPO’s L3.19-L3.21 
 
As a test reaction, we first tried to make L3.20 using similar methods as shown in scheme 
3.20 which involve the addition of 2-pyridyl magnesium bromide to a PhPCl2 solution at 
–20 oC. However, no desired product L3.20 was found. Instead, the double addition 
products pyridine containing phosphine L3.15 and the corresponding oxide 3.17 could be 
isolated as major products. A similar reaction was observed when we attempted to prepare 
L3.21 (see figure 3.3) with 2- pyridyl methyllithium (prepared from α-picoline and 
n-BuLi). Tertiary phosphine oxide (L3.18) was found as the only product instead of the 
desired product L3.21 (Scheme 3.26). The isolation of phosphine oxide L3.18 instead of 
the phosphine under this condition taking no precaution to prevent oxidation is 
understandable, as it is expected that the initial formed bis-alkylphosphine will be highly 























                                   L3.18 
 
Scheme 3.26 Synthesis of L3.15, 3.17 and L3.18 (Figure 3.2) 
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Upon replacing the Grignard reagents with lithium reagents, similar results were obtained. 
It has to be mentioned that even using exactly equal amounts of Grignard reagents and 
PhPCl2, the results are still the same. Presumably, the strong coordination of the pyridine 
moiety to the Grignard or lithium reagents directs the attack preferentially at the pyridine 





























Scheme 3.27 Proposed mechanism of reaction shown in scheme 3.26 
 
3.4 Resolution of secondary phosphine oxides (SPO’s) 
 
After the successful synthesis of all racemic ligands, their enantiopure forms could be 
obtained by preparative HPLC or classic resolution. Racemic ligand L3.4 (t-butyl phenyl 
phosphine oxide)25 was easy to separate on an AD column (n-heptane/2-propanol = 90/10) 
due to the large difference in the retention time of the two enantiomers (up to 20 g scale 







Figure 3.4 Separation of L3.4 with preparative HPLC (AD, n-heptane/2-propanol = 90/10) 
 
Both enantiomers can be obtained with e.e. >99% in 40%-45% yields. In the literature, the 
classical resolution with mandelic acid has also been described.26 However, it was found 
later that the results of classical resolution with mandelic acid or other resolving reagents 
were not reproducible by the same group.26b Haynes and coworkers reported another 
procedure via a 3-steps resolution on a large scale (up to 100 g), which was done by the 
oxidation of the racemic L3.4 with S8 to thiophosphoric acid 3.16, followed by the 
resolution thereof with chiral amines and subsequently by de-sulfurization with Raney-Ni 
to provide enantiopure L3.4.1b  
Other ligands L3.3 and L3.5-L3.11 could also be separated by preparative HPLC, although 
the separations were not always as effective as that of ligand L3.4. All separations were 
performed on a preparative HPLC (Daicel, chiralpak AD column, 250 x 20 mm i.d.). Both 
enantiomers could be separated with e.e.>99% in most cases. After resolution, the e.e.’s of 
these ligands were checked by analytical HPLC.  
Some ligands, like L3.14 and L3.17, could not be separated by preparative HPLC on the 
AD column. However, they could be separated by analytical HPLC on an OD column. As 
no preparative OD column was available, we were unable to obtain the enantiomers in 
reasonable quantities using the HPLC method.  
Due to non favorable geometry (need to bend the phenyl ring in order to coordinate to 
metal in bidentate way) of ligand L3.16 (two phosphorus atoms in meta position) when 




In summary, several symmetrical (L3.1 and L3.2) and unsymmetrical SPO’s (L3.3-L3.11, 
L3.14 and L3.16) as well as other non-SPO type ligands (L3.12-L3.13, L3.15 and 
L3.17-L3.18) were prepared in reasonable yields. In the reaction, the addition order is 
crucial for the preparation of SPO’s. The Grignard reagents should be added to the RPCl2 
solution at –20 oC and not the other way around, as otherwise the double addition products 
tertiary phosphine oxides were observed, and in some cases even as major products. The 
corresponding enantiopure forms of most unsymmetrical SPO’s except L3.14 (no 
 53
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separation on AD column) and L3.16 were resolved by preparative chiral HPLC. Attempts 
to the synthesis of pyridine-based SPO’s L3.19-L.21 failed and tertiary phosphine (L3.15) 
and phosphine oxide (3.17 and L3.18) were isolated as major products. 
 




Reagents were purchased from Aldrich, Acros, Fluka, Merck, Strem and used as received 
without any further purification unless stated otherwise. Most solvents were analytical 
grade and purified according to standard procedures, if necessary. 1H NMR (300 MHz), 13C 
NMR (75.4 MHz) and 31P NMR (75 MHz) spectra were recorded on a Varian VXR-300 
spectrometer in CDCl3. Chemical shifts were recorded in δ units (ppm) relative to the 
residue deuterated solvent signals of CHCl3 (1H: 7.25 ppm, 13C: 77.0 ppm). Coupling 
constants are recorded in Hertz (Hz). Melting points were measured on a Büchi B-545 
melting apparatus. Optical rotations were measured on a Perkin Elmer 241 polarimeter at 
ambient temperature. Mass spectra were measured on an AEI-MS-902 mass spectrometer 
by A. Kiewiet using electron impact ionization (EI, 70 eV) or chemical ionization (CI). The 
enantiomeric excess (e.e.) of the ligands were measured by analytical HPLC (Daicel, 
chiralpak AD or OD column, n-heptane/2-propanol, 95/5 or 90/10).  
 
Dimethyl phosphine oxide (L3.1)  
In a 250 ml 3-necked flask, was placed (EtO)2PHO (20 mmol, 2.6 ml) and freshly distilled 
dry Et2O (20 ml). A solution of MeMgBr (3 M in Et2O, 5 ml, 60 mmol) was 
added slowly at 0 oC. After addition, the mixture was allowed to warm to RT 
and stirred overnight. A solution of aq. K2CO3 (60 mmol, 8.28 g) in 10 ml of 
ice-cold water was added to the reaction mixture, followed by filtration. After washing 
with 20 ml of EtOH and removing the solvent, the residue was re-dissolved in 30 ml of 
CHCl3, 4 Å molecular sieves (10 g) were added and the mixture was stirred for 3 h then 
filtered and after removal of the solvent, a light yellow oil remained. The residue was 
further purified by vacuum distillation at 40-41 oC/1 Torr. (lit.27 65-67 oC/ 6 Torr.) to 
provide L3.127 as colorless oil, which solidified at 0oC. Isolated yield 59% (0.92 g, 11.8 
mmol). The spectral data were in accordance with the literature. 1H NMR (CDCl3) δ 0.32 
(dd, J = 0.7, 3.7 Hz, 3H, CH3), 0.39 (dd, J = 0.7, 3.7 Hz, 3H, CH3), 5.87 (dq, J = 3.7, 7.3, 
460.2 Hz, 1H, P-H). 13C NMR (CDCl3) δ 14.20, 12.85. 31P NMR (CDCl3) δ 18.91 (s). In 






Diphenyl phosphine oxide (L3.2) 
Prepared from Ph2PCl (50 mmol, 9.1 ml), THF (20 ml) and H2O (20 ml) at 0 oC for 1 h. 




chromatography (SiO2, EtOAC) to give L3.2 as a colorless sticky oil, which solidified at 
0oC. Isolated yield 87% (8.8 g, 43.5 mmol). The spectral data were in 
accordance with the literature.5a 1H NMR (CDCl3) δ 7.38-7.59 (m, 6H), 
7.62-7.69 (m, 4H), 8.00 (d, JP-H  = 481.2 Hz, 1H, P-H). 13C NMR (CDCl3) δ 







After 6 months in the air at RT, some sugar-like crystalline compound had formed in the 
sticky oil. Inspection of its 1H NMR and 31P NMR revealed that the typical P-H peak had 
disappeared, no P-H coupling could be observed and the 31P NMR signal had shifted to low 
field, which means the acid Ph2POOH had formed. 1H NMR (CDCl3) δ 7.29-7.54 (m, 6H), 
7.66-7.78 (m, 4H), 10.94 (s, 1H, POOH). 31P NMR (CDCl3) δ 32.46. The spectral data 
were in accordance with the authentic sample from Acros. 
 
trans-2,5-Dimethyl-1-phenylphospholane (3.3)  
This compound was prepared using a similar procedure as reported for DuPhos.  
In a 100 ml double Schlenk vessel, was placed PhPH2 (3 mmol, 4.8 ml, 10% wt% in 
n-hexane); the solution was cooled to 0 oC and a solution of n-BuLi (1.6 
M in n-hexane, 3.6 mmol, 2.25 ml) was added dropwise via syringe. The 
pale yellow solution was allowed to stir for 1 h at 0 oC. To the resulting 
mixture was then slowly added a THF solution (10 ml) of racemic trans 
cyclic sulfite 3.228 (3 mmol, 0.54 g). After the solution was stirred for 2 h, n-BuLi (1.6 M in 
n-hexane, 3.6 mmol, 2.25 ml) was added again in a similar way. The mixture was allowed 
to stir for 1.5 h, after which 3 ml of MeOH was added to quench the remaining excess 
n-BuLi. The resulting colorless mixture was concentrated and extracted with 100 ml 
pentane under N2 and filtered. The solvent was removed to yield racemic trans 3.311 as a 
colorless sticky oil. Isolated yield 71% (0.4 g, 2.1 mmol). The spectral data were in 
accordance with the literature. 1H NMR (CDCl3) δ 0.73 (dd, J = 7.0, 11.0 Hz, 3H, CH3), 
0.81-0.97 (m, 2H, CH2), 1.27(dd, J = 7.0, 18.7 Hz, 3H, CH3), 1.87-1.96 (m, 1H, CH), 
2.12-2.31 (m, 2H, CH2), 2.62-2.70 (m, 1H, CH), 7.21-7.29 (m, 3H), 7.42-7.66 (m, 2H). 31P 
NMR (CDCl3) δ 10.18 (s) (lit.  10.0). 
P
Ph
The compound was then re-dissolved in 30 ml dry THF and transferred to another 100 ml 
double Schlenk vessel. Under argon, Li powder (0.5 g, 30% in mineral oil, 70 mmol, 
excess) was added and the mixture stirred at RT overnight. The mixture was then 
hydrolyzed carefully with Na2SO4.10H2O, filtered and the solvent was removed to give a 
light yellow oil, 31P NMR (CDCl3) δ -174.7 (In C6D6, -28.9). When the NMR tube was left 
open in the air for 1 d, a complicated 31P NMR spectrum was found and no major product 
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1-(Dimethylamino)-2,5-diphenyl-2,5-dihydro-1H-1λ5-phosphol-1-one (3.6)  
In a 100 ml Schlenk flask, was placed AlCl3 (52 mmol, 7 g) and dry DCM (20 ml). After 
stirring for 30 min at RT under N2, the solution was cooled to –30 oC. A solution of 
(CH3)2NPCl2 (35 mmol, 4 ml) and dry DCM (5 ml) was added to this mixture. After 1 h, 
the solution was allowed to warm to RT, which resulted in the 
formation of a slightly yellow turbid solution. It was then cooled to –20 
oC, and 1,4-diphenyl-1,3-butadiene (35 mmol, 7.2 g) in DCM (10 ml) 
was slowly added. After addition, a green solution was formed which 
then slowly turned into dark-red. The solution was allowed to warm to 
RT overnight. 31P NMR (CDCl3) δ 111.62 (s, phosphorium chloride salt). It was then 
slowly poured into an ice-cold saturated aq. EDTA:NaHCO3 = 30:30 ml solution. After 6 h 
at 0 oC, the solution was allowed to warm to RT, extracted with 3 x 50 ml DCM, washed 
with brine (3 x 50 ml) and dried over MgSO4. After filtration and removing the solvent 
under vacuum, 3.6  was obtained as yellow oil. Isolated yield 92% over two steps (9.6 g, 
32.2 mmol). The spectral data were in accordance with the literature. 1H NMR (CDCl3) δ 
1.81 (s, 3H, CH3), 1.83 (s, 3H, CH3), 4.22 (s, 1H, CH), 4.28 (s, 1H, CH), 6.44 (s, 1H, =CH), 
6.53 (s, 1H, =CH), 7.16-7.27 (m, 10H). 13C NMR (CDCl3) δ 133.26 (d, J = 8.01 Hz), 
133.16, 128.28, 128.07, 125.98, 125.95, 124.57, 124.51, 124.25, 124.20, 47.08, 46.15, 






Using a similar procedure, starting from 2,4-hexadiene [mixture of (2E,4E) and (2E,4Z), 
1.35 g, 15 mmol] and (CH3)2NPCl2 (1.7 ml, 15 mmol). 3.5 was 
obtained as light yellow sticky oil. Isolated yield 45% over 2 steps (1.2 
g, 6.75 mmol). 1H NMR (CDCl3) δ 0.97 (d, J = 7.3 Hz, 3H, CH3), 1.05 
(d, J = 7.3 Hz, 3H, CH3), 2.49 (s, 3H, CH3), 2.53 (s, 3H, CH3), 
2.58-2.67 (m, 2H, 2CH), 5.52 (d, J = 1.5 Hz, 1H, =CH), 5.65 (d, J = 1.2 Hz, 1H, =CH). 13C 
NMR (CDCl3) δ 142.60, 142.13, 33.31, 33.10, 32.94, 30.84, 10.38, 10.19. 31P NMR 
(CDCl3) δ 76.92 (s). After reduction with 10% Pd/C at 50 bar H2 in 
DCM followed by treatment with MeONa in MeOH, the saturated 
trans 3.7 was isolated as colorless oil. Isolated yield 77% over 2 steps 
(0.9 g, 5.2 mmol). 1H NMR (CDCl3) δ 1.06 (d, J = 7.0 Hz, 3H, CH3), 
1.11 (d, J = 7.0 Hz, 3H, CH3), 1.47-1.53 (m, 2H), 1.98-2.09 (m, 4H), 
2.67 (s, 3H, CH3), 2.69 (s, 3H, CH3). 13C NMR (CDCl3) δ 35.10, 35.04, 33.12, 31.54, 28.35, 









Compound 3.6 (9.6 g, 32.2 mmol) was dissolved in DCM (30 ml) and hydrogenated using 




The solvent was removed under vacuum. The residue was purified by flash column 
chromatography (SiO2, n-hexane:EtOAc, 1:1) to provide 3.8  as off-white solid. Isolated 
yield 95% (9.15 g, 30.6 mmol). The spectral data were in accordance 
with the literature. 1H NMR (CDCl3) δ 1.79 (s, 3H, CH3), 1.82 (s, 3H, 
CH3), 2.46-2.52 (m, 4H, 2CH2), 3.56-3.67 (m, 2H, 2CH), 7.19-7.31 (m, 
10H). 13C NMR (CDCl3) 135.12 (d, J = 2.5 Hz), 126.87, 125.41, 125.33, 
124.84, 44.76, 43.31, 33.71, 25.26, 25.01. 31P NMR (CDCl3) δ 67.18 (s). 
After treatment with MeONa in MeOH overnight, the trans compound of 3.8 was obtained 






Trans 3.8 (0.59 g, 1.97 mmol) was hydrolyzed with 6 N aq. HCl (20 ml) under reflux 
overnight. After work-up and removing the solvents, the residue was further purified by 
flash column chromatography (SiO2, CHCl3: MeOH, 9:1) to give 3.9 as 
light yellow powder. Isolated yield 78% (0.42 g, 1.54 mmol). The 
spectral data were in accordance with the literature. mp. 198-201 oC 
(dec.). (lit.  227-228 oC). 1H NMR (CD3OD) δ 1.13-1.1.39 (m, 1H), 
2.14-2.51 (m, 3H), 3.28-3.32 (m, 1H, CH), 3.55-3.65 (m, 1H, CH), 7.24-7.35 (m, 10H). 13C 
NMR (CD3OD) δ 138.08 (d, J = 4.9 Hz), 136.10, 135.49, 133.80, 127.08, 126.69, 126.41, 
125.68, 125.02, 124.14, 44.12, 42.27, 32.70, 28.01. 31P NMR (CD3OD) δ 59.75 (s). MS 
(EI+) 273 (M+1), 272 (M), 271 (M-1), 206, 205, 168, 129, 117, 105, 104 (100 %), 103, 91, 






Trans 3.8 (0.6 mmol, 0.18 g) was dissolved in 15 ml of dry toluene; to this solution was 
added Si2Cl6 (0.62 mmol, 0.14 ml). The solution was heated to reflux overnight under air, 
the solvent was removed and the residue was purified by flash column 
chromatography (SiO2, EtOAc) to give L3.3  as white crystals. Isolated 
yield 36% (55.3 mg, 0.22 mmol). The spectral data were in accordance 
with the literature.14 1H NMR (CDCl3) δ 1.87-2.20 (m, 1H), 2.22-2.67 (m, 
3H), 3.20-3.35 (m, 1H, CH), 3.43-3.67 (m, 1H, CH), 7.11 (d, JP-H = 471.5 Hz, 1H, P-H), 
7.30-7.39 (m, 10H). 13C NMR (CDCl3) δ 134.92 (d, J = 3.4 Hz), 133.76 (d, J = 6.1 Hz), 
127.75, 127.64, 127.28, 127.13, 126.91, 126.09, 125.91(d, J = 3.0 Hz), 125.75 (d, J = 2.4 
Hz), 47.20 (d, JP-C  = 60.3 Hz), 43.78 (d, JP-C  = 59.9 Hz), 31.48 (d, J = 7.3 Hz), 26.97 (d, J 
= 11.1 Hz). 31P NMR (CDCl3) δ 54.05 (s). MS (EI+) 257 (M+1), 256 (M, 100%), 255 (M-1), 
207, 206, 152, 151, 139, 138, 134, 131, 129, 117, 105, 104, 91, 78, 77, 65, 51. HRMS (EI+) 




The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-heptane/2-propanol = 75/25, t1 
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= 10.5 min, t2 = 13.1 min.  
 
General procedure for the synthesis of L3.4, L3.5, L3.10, L3.14, L3.16 (Scheme 
3.20-3.21) 
 
In a 500 ml 3-necked round flask under N2 were placed Mg turnings and freshly distilled 
dry THF (100 ml). A solution of t-BuCl (for L3.4), 2-bromo-1-naphthalene (for L3.10), 
2-methoxy-phenyl bromide (for L3.14) and 3.14 {[3-(diphenylphosphino) phenyl] bromi- 
de} (for L3.16) in 100 ml dry THF was added via a dropping funnel. After the reaction 
starts, the addition was continued slowly to maintain a gentle reflux during approx. 40 min. 
After addition, the solution was kept refluxing for 2 h under N2. Then the freshly prepared 
Grignard reagent was cooled and added slowly to a solution of PhPCl2 in 80 ml THF via a 
double-ended needle at -20 oC. After addition, the solution was allowed to warm to RT and 
heated to reflux for 3 h. The solution was cooled to 0 oC and 50 ml of H2O was added 
followed by 2 M aq. HCl (20 ml). The mixture was extracted with Et2O (3 x 100 ml). The 
combined organic layers were washed with saturated aq. NaHCO3 (3 x 50 ml) and brine (3 
x 50 ml), dried over MgSO4 and filtered. The solvent was removed under vacuum and the 
residue was further purified by vacuum distillation or flash column chromatography (SiO2, 
EtOAc).  
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.) with n-hexane/ethanol or n-heptane/2-propanol as eluents. 
 
tert-Butyl(oxo)phenylphosphorane (L3.4)1b  
Prepared from t-BuCl (0.55 mol, 60 ml), Mg turnings (0.558 mol, 13.4 g) and PhPCl2 (0.54 
mol, 73 ml). After work-up and remove all the solvent, the residue was 
purified by vacuum distillation 110-120 oC/0.8 Torr (lit. 1b bp 110 °C/0.8 
Torr.) to give L3.41b as colorless oil, which solidified upon standing to a 
white semi-solid. Isolated yield 86% (83.7 g, 0.46 mol). The spectral data 
were in accordance with the literature. 1b 1H NMR (CDCl3) δ 1.08 (dd, JC-H  
= 1.2 Hz, JP-CH  = 16.6 Hz, 9H, CH3), 6.98 (d, 1H, JP-H = 454.6 Hz), 7.38-7.67 (m, 5H). 13C 
NMR (CDCl3) δ 130.74, 129.16, 128.96, 126.83 (d, J = 90.0 Hz), 126.82, 126.59, 30.01 (d, 
J = 69.4 Hz), 21.59. 31P NMR (CDCl3) δ 47.32 (s). MS (EI+) 183 (M+1), 182 (M), 181 
(M-1), 149, 126, 109, 108, 91, 83, 80, 79 (100%), 77, 57, 51, 48 HRMS (EI+) M+ for 




The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-heptane/2-propanol = 90/10, t1 
= 11.0 min, mp 73-75 oC, [α]D = -33.5 o (c = 0.251, CHCl3), (lit. 1b mp 71-73 °C, [α] D = 
-32.45 o (c = 1.20, CHCl3), t2 = 15.3 min, mp 75-77 oC, [α]D = +29.5 o (c = 0.305, CHCl3) 
(lit. 1b [α]D = +33.2 o (c = 1.29, CHCl3). 




phosphoric acid.29 In the refrigerator, this process was much slower than at RT and only 
10% of phosphoric acid was found. This observation was based on 31P and 1H NMR. 1H 
NMR (CDCl3) δ 1.04 (d, J = 15.9 Hz, 9H, 3CH3), 7.32-7.68 (m, 3H), 7.70-7.78 (m, 2H), 
11.83 (s, 1H, POOH). 31P NMR (CDCl3) δ 52.77 (s). MS (EI+) 199 (M+1), 198 (M, 24%), 
143, 142 (100%), 78, 77, 57, 51. 
 
Isopropyl(oxo)phenylphosphorane (L3.5) 
Prepared from i-PrMgCl (2 M solution in THF, 20 mmol, 10 ml) and PhPCl2 (32 mmol, 4.5 
ml). After work-up and removal of the solvent, the residue was purified by flash column 
chromatography (SiO2, EtOAc) to give L3.5 as a colorless oil. Isolated 
yield 36% (1.2 g, 7.2 mmol). 1H NMR (CDCl3) δ 1.08-1.24 (dd, J = 6.1, 6.6, 
6.8 Hz, 6H, 2CH3), 2.03-2.22 (m, 1H), 7.22 (dd, J = 2.2, 458.3 Hz, 1H), 
7.31-7.74 (m, 5H). 13C NMR (CDCl3) δ 129.81, 127.71, 127.56, 126.50 (d, 
J = 94.0 Hz), 126.12, 125.96, 25.70 (d, J = 69.6 Hz), 12.34, 11.76. 31P 
NMR (CDCl3) δ 39.38 (s). MS (EI+) 168 (M), 167 (M-1), 126, 125, 124, 79 (100%), 77, 51, 
47. HRMS (EI+) M+ for C9H13OP, found 168.0726, cal. 168.0704. 
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-hexane/ethanol = 92.5 /7.5, t1 = 
15.1 min, [α]D = -14.4 o (c = 0.25, CHCl3), t2 = 17.3 min, [α]D = +11.2 o (c = 0.285, CHCl3). 
Both enantiomers are colorless sticky oils. 
 
Diisopropyl(phenyl)phosphine oxide (3.18) 
PhPCl2 (65 mmol, 8.82 ml) in THF (50 ml) was added slowly to a solution of i-PrMgCl (2 
M in THF, 60 mmol, 30 ml) at –20 oC. The solution was allowed to warm 
to RT and stirred overnight. After work-up and removal of the solvent, the 
residue was further purified by vacuum distillation (112 oC/ 0.04 Torr.) to 
give 3.18 as a colorless oil. Isolated yield 55% (6.9 g, 33 mmol). 1H NMR 
(CDCl3) δ 0.98 (dd, J = 7.3, 16.1 Hz, 6H, 2CH3), 1.13 (dd, J = 7.3, 15.0 Hz, 6H, 2CH3), 
2.18-2.31 (m, 1H, CH), 7.22-7.46 (m, 3H), 7.58-7.64 (m, 2H). 13C NMR (CDCl3) δ 130.12, 
129.97, 126.87, 126.66, 28.19, 24.28, 22.94, 14.47, 13.43. 31P NMR (CDCl3) δ 50.65 (s). 









Prepared from 2-bromo-naphthalene (24 mmol, 5.04 g), Mg turnings 
(50 mmol, 1.2 g) and PhPCl2 (26 mmol, 3.5 ml). After work-up and 
removal of the solvent, the residue was purified by flash column 
chromatography (SiO2, EtOAc) to give L3.10 as a white solid. Isolated 
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7.01-7.35 (m, 6H), 7.72 (d, JP-H  = 483.2 Hz, 1H), 7.90 (d, J = 15.6 Hz, 1H). 13C NMR 
(CDCl3) δ 133.07 (d, JP-C = 2.3 Hz), 130.92, 130.71, 130.43, 128.91, 128.68, 127.74, 
127.19, 126.94, 126.88, 126.57, 126.12, 125.73, 125.33, 123.31, 123.07. 31P NMR (CDCl3) 
δ 20.28 (s). MS (EI+) 253 (M+1), 252 (M), 251 (M-1, 100%), 233, 205, 202, 173, 128, 127, 
77. HRMS (EI+) M+ for C16H13OP, found 252.0692, calcd. 252.0704.  
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-hexane/2-propanol = 56/44, t1 = 
22.4 min, mp 73-75 oC, [α]D= -5.2 o (c = 0.27, CHCl3), t2 = 26.9 min, mp 81-83 oC, [α]D = 
+6.0 o (c = 0.25, CHCl3) (lit.30 mp 184-186 oC, [α]D = -0.59 o, in the literature, these data 
might be for the corresponding phosphoric acid). 
 
Di(2-naphthyl)phenylphosphine oxide (3.19)31
PhPCl2 (27 mmol, 3.7 ml) in THF (20 ml) was added slowly to 2-naphthylMgBr [prepared 
from 2-bromo-1-naphthalene (24 mmol, 5.02 g) and Mg turnings 
(50 mmol, 1.2 g)] at –20 oC. The solution was allowed to warm to 
RT and stirred overnight. After work-up and removal of the solvent 
to give 3.19 as a white semi-solid. Isolated yield 30% (2.7 g, 7.2 
mmol). The spectral data were in accordance with the literature. 1H 
NMR (CDCl3) δ 7.42-7.94 (m, 17H), 8.29 (d, J = 0.7 Hz, 1H), 8.36 (d, J = 0.7 Hz, 1H). 31P 
NMR (CDCl3) δ 29.18 (s). MS (EI+) 379 (M+1), 378 (M), 377 (M-1, 100), 376, 328, 254, 





Prepared from 2-methoxy-1-bromo-benzene (52 mmol, 6.5 ml), Mg turnings (65 mmol, 
1.56 g) and PhPCl2 (50 mmol, 6.8 ml). After work-up and removal of the 
solvent, the residue was purified by flash column chromatography (SiO2, 
EtOAc) to give L3.14  as a white solid. Isolated yield 29% (3.4 g, 14.5 
mmol). The spectral data were in accordance with the literature. mp 97-99 
oC (some impurity in the sample, lit.  105-106 oC). 1H NMR (CDCl3) δ 3.76 
(s, 3H, OCH3), 6.90 (d, J = 13.9 Hz, 1H), 7.05-7.12 (m, 1H), 7.39-7.67 (m, 4H), 7.71-7.83 
(m, 3H), 8.15 (d, J P-H  = 501.0 Hz, 1H, P-H). 13C NMR (CDCl3) δ 158.91, 158.84 (d, J = 
3.4 Hz), 132.99, 131.19, 131.06, 130.49, 129.94, 128.82, 128.59, 127.01, 126.74, 119.50, 
119.26, 118.03, 115.99, 109.34, 109.22, 53.86. 31P NMR (CDCl3) δ 14.36 (s). MS (EI+) 233 
(M+1), 232 (M), 231 (M-1), 214, 213, 203, 201, 199, 196, 183, 167, 141, 91, 78, 77, 47. 





We were unable to separate L3.14 on preparative HPLC (Daicel, chiralpak AD column, 
250 x 20 mm i.d.) with different solvents combination. It could only be separated on an 
analytical HPLC column (Daicel, chiralpak OD column, 250 x 4.6 mm i.d.), flow rate 1 




21.0 min. However, a preparative OD column for HPLC was not available. 
 
tert-Butyl[3-(diphenylphosphino)phenyl]oxophosphorane (L3.16) 
In a 250 ml 3-round flask, was placed 1,3-dibromo-benzene (50 mmol, 6.1 ml) in dry THF 
(50 ml). The mixture was cooled to –78 oC and a solution of n-BuLi (1.6 M 
in n-hexane, 51 mmol, 32 ml) was added. This temperature was maintained 
for 1 h, and subsequently a solution of Ph2PCl (50 mmol, 9.1 ml) in 50 ml of 
THF was added slowly. The solution was allowed to come to RT and 50 ml 
of water was added followed by extraction with Et2O (3 x 100 ml). The ether layer was 
washed with brine (3 x 50 ml) and dried over MgSO4. After removal of the solvent, the 
residue was purified by flash column chromatography [SiO2, petroleum ether (40-60 
oC):Et2O, 1:1] to give 3.14  as a yellow sticky oil. Isolated yield 89% (15.1 g, 44.5 mmol). 
The spectral data were in accordance with the literature. 1H NMR (CDCl3) δ 7.05-7.89 (m, 
14H). 13C NMR (CDCl3) δ 139.09 (d, J =15.6 Hz), 134.94, 134.73, 134.32, 132.54, 132.15, 
130.85, 130.47, 130.25, 128.67, 128.53, 127.64, 127.31, 127.17, 126.41, 126.26, 121.73, 
121.59. 31P NMR (CDCl3) δ –5.15 (s). MS (EI+) 342, 341 (M+1), 340 (M, 100%), 339 
(M-1), 261, 185, 184, 183, 152, 131, 108, 107, 91, 79, 77, 65. 
PPh2
Br
Prepared from 3.14 (6 mmol, 2.1 g), Mg turnings (12 mmol, 0.4 g) and PhPCl2 (7 mmol, 
1.0 ml). After work-up and removal of the solvent, the residue was purified 
by flash column chromatograph (SiO2, EtOAc) to give L3.16 as colorless 
sticky oil. Isolated yield 30% (0.69 g, 1.8 mmol). 1H NMR (CDCl3) δ 
7.20-7.78 (m, 19H), 7.94 (d, JP-H = 483.4 Hz, 1H, P-H). 13C NMR (CDCl3) 
δ 139.09 (d, J = 15.6 Hz), 134.54, 134.35, 134.32, 132.54, 132.15, 130.85, 
130.47, 130.25, 128.67, 128.53, 128.27, 127.64, 127.31, 127.17, 126.41, 126.26. 31P NMR 
(CDCl3) δ –5.78 (s), 20.92 (s). MS (EI+) 388, 387 (M+1), 386 (M, 100%), 385 (M-1), 259, 
257, 185, 184, 183, 154, 108, 107, 77. HRMS (EI+) M+ for C24H20OP2, calcd. 386.0989, 






General procedure for the synthesis of L3.6-L3.9, L3.11 (Scheme 3.22-3.23) 
 
In a 250 ml 3-necked round bottom flask under N2 were placed Mg turnings and freshly 
distilled dry THF (50 ml). A solution of 2-bromo-1-naphthalene (for L3.6), t-BuCl (for 
L3.9), 2-methoxy-1-bromo-benzene (for L3.7), 3, 5-dimethy-1-bromo-benzene (for L3.8), 
3.15 {[2-(diphenylphosphino) phenyl] bromide} (for L3.11) in 50 ml of dry THF was 
added via a dropping funnel. After the reaction starts, the remaining solution was slowly 
added to maintain gentle reflux (40 min). After the addition was complete, heating at reflux 
was continued for 2 h under N2. Then the freshly prepared Grignard reagents were cooled 
and added slowly to a solution of t-BuPCl2 or 3.12 (mesityl-PCl2) (for L3.9) in 50 ml of 
THF via a canula at -20 oC. After addition was complete, the solution was allowed to warm 
to RT and heated to reflux for 3 h to go to completion. After cooling to 0 oC, 50 ml of H2O 
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followed by 2 M HCl (20 ml) were added slowly to dissolve some magnesium salts. After 
extraction with Et2O (3 x 100 ml), the combined organic layers were washed with saturated 
NaHCO3 (3 x 50 ml) and brine (3 x 50 ml), dried over MgSO4 and the solvent was removed 
under vacuum. The residue was further purified by flash column chromatography (SiO2, 
EtOAc).  
The ligands were separated into their enantiomers by preparative HPLC (Daicel, chiralpak 






Prepared from 2-bromo-1-naphthalene (85 mmol, 17.6 g), Mg turnings (100 mmol, 2.4 g) 
and t-BuPCl2 (72 mmol, 11.5 g). After work-up and removal of the 
solvent, the residue was purified by flash column chromatography 
(SiO2, EtOAc) to give L3.6 as a white power. Isolated yield 14% (2.34 
g, 10.1 mmol). 1H NMR (CDCl3) δ 1.18 (d, J = 16.6 Hz, 9H, 3CH3), 
7.17 (d, JP-H = 453.9 Hz, 1H), 7.55-7.71 (m, 4H), 7.86- 7.96 (m, 3H), 
8.24 (d, 1H, J = 14.4 Hz). 13C NMR (CDCl3) δ 133.54 (d, JP-C = 12.6 Hz), 131.37, 130.65, 
127.17, 126.72, 126.40, 125.54, 124.23, 124.02, 123.51, 30.72 (d, JP-C = 69.1 Hz), 21.96. 
31P NMR (CDCl3) δ 47.03 (s). MS (EI+) 233 (M+1), 232 (M), 176, 130, 129, 128, 127, 77, 
57, 47. HRMS (EI+) M+ for C14H17OP, found 232.1012, calcd. 232.1017. 
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow 20 ml/min, 254 nm, n-hexane/ethanol = 67/33, t1 = 5.6 min, 
mp 129-131 oC, [α]D = -38.8 o (c = 0.245, CHCl3), t2 = 7.9 min, mp 138-140 oC, [α]D = 
+38.5 o (c = 0.275, CHCl3). 
When t-BuPCl2 was added to 2-naphthyl-MgBr solution at –20 oC, only about 15% based 
on 31P NMR of the desired product was found in the crude mixture after work-up. 
 
tert-Butyl(2-methoxyphenyl)oxophosphorane (L3.7) 
Prepared from 2-methoxy-1-bromo-benzene (63 mmol, 7.85 ml), Mg turnings (100 mmol, 
2.4 g) and t-BuPCl2 (62.9 mmol, 10.0 g). After work-up and removal of 
the solvent, the residue was purified by flash column chromatography 
(SiO2, EtOAc) to give L3.7 as a colorless oil. Isolated yield 68% (9.1 g, 
42.8 mmol). 1H NMR (CDCl3) δ 1.15 (d, J = 17.1 Hz, 9H, 3CH3), 3.83 (s, 
3H, OCH3), 7.36 (d, 1H, P-H, JP-H  = 484.4 Hz), 6.86-6.93 (m, 1H), 
7.01-7.08 (m, 1H), 7.43-7.51 (m, 1H), 7.63-7.73 (m, 1H). 13C NMR (CDCl3) δ 159.35 (d, J 
= 4.2 Hz), 132.45, 132.42, 131.90, 131.79, 119.35, 119.14, 116.61 (d, J = 118.3 Hz), 115.31 
(d, J = 90.4 Hz), 109.18, 109.05, 53.71, 32.18 (d, J = 56.5 Hz), 30.92 (d, JP-C  = 71.0 Hz), 
22.80, 22.09, 22.06. 31P NMR (CDCl3) δ 35.58 (s). MS (EI+) 213 (M+1), 212 (M), 156, 155, 
149, 141, 139, 138, 137, 125, 109 (100%), 107, 94, 91, 79, 77, 65, 57, 51, 47. HRMS (EI+) 








The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-hexane/ethanol = 67/33, t1 = 4.0 
min, [α]D = -15.1 o (c = 0.35, CHCl3), t2 = 5.9 min, [α]D = +11.8 o (c = 0.365, CHCl3). Both 
enantiomers are colorless sticky oils. 
 
tert-Butyl(3,5-dimethylphenyl)oxophosphorane (L3.8) 
Prepared from 3, 5-dimethyl-1-bromo-benzene (63 mmol, 8.6 ml), Mg turnings (2.4 g, 100 
mmol) and t-BuPCl2 (62.9 mmol, 10.0 g). After work-up and removal of 
the solvent, the residue was purified by flash column chromatography 
[SiO2, petroleum ether (40-60 oC):EtOAc, 1:1] to give L3.8 as a white 
solid. Isolated yield 65% (8.6 g, 40.9 mmol). 1H NMR (CDCl3) δ 1.13 (d, 
J = 16.6 Hz, 9H, 3CH3), 2.35 (s, 6H, 2CH3), 6.95 (d, JP-H  = 452.4 Hz, 1H, 
P-H), 7.17 (s, 1H, CH), 7.28 (s, 1H, CH), 7.22 (s, 1H, CH). 13C NMR 
(CDCl3) δ 136.65 (d, JP-C  = 12.6 Hz), 132.77, 127.30, 127.01, 126.79, 125.49, 30.24 (d, 
JP-C  = 69.1 Hz), 21.87, 21.84, 19.62. 31P NMR (CDCl3) δ 47.76 (s). MS (EI+) 211(M+1), 
210 (M), 170, 154, 153, 107 (100%), 105, 91, 79, 77, 57, 47. HRMS (EI+) M+ for C12H19OP, 




The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-hexane/ethanol = 92.5/7.5, t1 = 
7.2 min, mp 144-147 oC, [α]D = +9.4 o (c = 0.265, CHCl3), t2 = 17.3 min, mp 136-138 oC, 
[α]D = -9.8 o (c = 0.275, CHCl3). 
 
tert-Butyl(mesityl)oxophosphorane (L3.9) 
In a 250 ml 3-necked round flask, 2-bromomesitylene (50 mmol, 7.7 ml) in 20 ml of dry 
Et2O was cooled to –20 oC and a solution of n-BuLi (1.6 M in n-hexane, 60 mmol, 37.5 ml) 
was added under N2. After addition, the solution was allowed to warm to RT and heated to 
reflux for 3 h and cooled to –78 oC. A solution of PCl3 (65 mmol, 5.8 ml) 
in 30 ml of Et2O was added via a dropping funnel in 40 min. After 
addition, the solution was allowed to warm to RT overnight. The solvent 
was removed under vacuum and the desired product was purified by 
vacuum distillation 90-95 oC / 0.07 Torr. (lit.33 80 oC / 0.03 Torr.) to give 3.1233,34 as a 
colorless sticky oil. Isolated yield 81% (40.5 mmol, 8.95 g). The spectral data were in 
accordance with the literature.33,34 1H NMR (CDCl3) δ 6.92 (s, 1H, CH), 6.90 (s, 1H, CH), 
2.73 (s, 3H, CH3), 2.71 (s, 3H, CH3), 2.37 (s, 3H, CH3). 31P NMR (CDCl3) δ 160.97 (s). 
(lit.34 161.0). 
PCl2
Compound 3.12 (40.5 mmol, 8.95 g) was immediately dissolved in 50 ml 
of dry THF under N2 and a preformed solution of t-BuMgCl in THF 
[prepared from t-BuCl (60 mmol, 6.5 ml) and Mg turnings (80 mmol, 1.92 
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RT overnight. After work-up and removal of the solvent, the residue was purified by flash 
column chromatography (SiO2, n-hexane:EtOAc, 1:1) to give L3.9 as a colorless oil. 
Isolated yield 21% over 2 steps (2.35 g, 10.5 mmol). 1H NMR (CDCl3) δ 1.16 (d, JP-H  = 
16.6 Hz, 9H, 3CH3), 2.22 (s, 3H, CH3), 2.49 (br, 6H, 2CH3), 6.83 (br, 2H, 2CH), 7.55 (d, 
JP-H  = 455.6 Hz, 1H). 13C NMR (CDCl3) δ 139.79 (d, JP-C  = 2.3 Hz), 128.67, 128.12, 
120.23 (d, JP-C  = 88.1 Hz), 32.70 (d, JP-C  = 69.1 Hz), 22.78, 22.72, 20.45, 20.35, 19.12. 31P 
NMR (CDCl3) δ 38.16 (s). MS (EI+) 225 (M+1), 224 (M), 223 (M-1), 182, 168 (M-1-t-Bu), 
167 (M-t-Bu), 151, 122, 121 (100%), 120, 119, 105, 91, 77, 57. HRMS (EI+) M+ for 
C13H21OP, found 224.1341, calcd. 224.1330. 
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-heptane/2-propanol = 95/5, t1 = 
9.0 min, mp 109.5-112 oC, [α]D= -16.9 o (c = 0.255, CHCl3), t2 = 13.7 min, mp 105-107 oC, 
[α]D = +20.4 o (c = 0.275, CHCl3). 
 
tert-Butyl[2-(diphenylphosphino)phenyl]oxophosphorane (L3.11) 
In a 250 ml 3-necked round flask, was placed Mg turnings (70 mmol, 1.68 g) and 50 ml of 
freshly distilled dry THF. A solution of 1,2-dibromo-benzene (50 mmol, 
6.0 ml) in dry THF (50 ml) was added via a dropping funnel. After the 
reaction starts, the addition was continued slowly to maintain gentle reflux 
(40 min). After the addition was completed, refluxing was continued for 1 h under N2. 
After cooling to –20 oC, a solution of Ph2PCl (50 mmol, 9.1 ml) in 50 ml of THF was 
slowly added. The temperature was allowed to rise to RT, 50 ml of water was added and the 
mixture was extracted with Et2O (3 x 100 ml), washed with brine (3 x 50 ml) and dried over 
MgSO4. After removal of the solvent, the residue was purified by flash column 
chromatography [SiO2, petroleum ether (40-60 oC):Et2O, 1:1] to give 3.1535 as a yellow 
sticky oil. Isolated yield 50% (8.5 g, 25 mmol). 1H NMR (CDCl3) δ 6.88-6.94 (m, 1H), 
7.23-7.51 (m, 12H), 7.71-7.76 (m, 1H). 13C NMR (CDCl3) δ 137.57 (d, J = 11.8 Hz), 
135.75, 134.58, 134.37, 133.13, 132.88, 132.79, 132.47, 132.06, 131.64, 128.83, 127.71, 
127.43, 127.28, 127.04, 126.76, 126.09, 125.10. 31P NMR (CDCl3) δ –5.31 (s). MS (EI+) 
342 (M+1), 341 (M, 95%), 340 (M-1), 339, 337, 277, 261, 259, 228, 184, 183 (100%), 157, 
152, 130, 107, 91, 77, 51. 
Br
PPh2
Prepared from 3.15 (14.7 mmol, 5.0 g), Mg turnings (30 mmol, 0.72 g) and t-BuPCl2 (14 
mmol, 2.27 g). After work-up and removal of the solvent, the residue was 
purified by flash column chromatography (SiO2, EtOAc) to provide L3.11 
as colorless sticky oil. Isolated yield 35% (1.8 g, 4.9 mmol). 1H NMR 
(CDCl3) δ 1.04 (d, J = 16.4 Hz, 9H, 3CH3), 6.93-7.48 (m, 13H), 7.77-7.86 
(m, 1H), 7.94 (dd, J = 5.4, 471.2 Hz, 1H, P-H). 13C NMR (CDCl3) δ 138.99 
(dd, JP-C = 9.2, 29.0 Hz), 133.83 (dd,  J = 28.3, 87.4 Hz), 134.22 (d, J = 9.9 









127.41, 127.21, 127.07, 31.77 (d, J = 68.3 Hz), 22.78 (d, J = 2.3 Hz). 31P NMR (CDCl3) δ 
–16.03 (d, JP-P  = 70.1 Hz), 35.87 (d, JP-P  = 67.8 Hz). MS (CI+) 384 (M+NH4+), 383 
(M-1+NH4+), 368, 367 (M+1, 100%), 338, 325, 309, 278, 277, 248, 225, 200, 183, 147, 85, 
64. 
The ligand was separated into its enantiomers by preparative HPLC (Daicel, chiralpak AD 
column, 250 x 20 mm i.d.), flow rate 20 ml/min, 254 nm, n-hexane/2-propanol = 85/15, t1 = 
5.6 min, t2 = 7.7 min. Both enantiomers are colorless sticky oils. 
 
(1R, 7R)-9,9-Dimethyl-4-hydrido-4-oxo-2, 2, 6, 6-tetraphenyl-3, 5, 8, 10-tetraoxa-4- 
phosphabicyclo [5.3.0] decane (L3.12)36  
 
In a 100 ml Schlenk vessel, was placed {5-[hydroxy(diphenyl)methyl]-2,2–dimethyl- 
1,3-dioxolan-4-yl(diphenyl)methanol} (2 mmol, 0.94 g) (R, R-Taddol) and dry toluene (5 
ml). The solution was cooled to –78 oC and PCl3 (3.0 mmol, 0.26 ml) 
was added in 20 min. The solution was allowed to warm to RT and 
stirring was continued for 3 h. The solution was cooled down to 0 oC 
and H2O (5 ml) was slowly added. After the addition was complete, 
the solution was allowed to warm to RT and stirred for 30 min. After 
extraction with CH2Cl2 (3 x 20 ml), washing with brine (3 x 50 ml) and drying over MgSO4, 
the solvent was removed. The residue was purified by flash column chromatography (SiO2, 
n-hexane:EtOAc, 1:1) to give L3.12  as a white powder. Isolated yield 75% (0.77 g, 1.5 
mmol). The spectral data were in accordance with the literature. mp 224-226 oC (dec.), 
[α]D = -268.4 o (c = 0.275, CHCl3), [lit.  mp 226-227 oC (dec.), [α]D = -289.9 o, c = 1.56, 
CHCl3], 1H NMR (CDCl3) δ 0.56 (s, 3H, CH3), 0.76 (s, 3H, CH3), 5.21 (d, J = 7.8 Hz, 1H, 
CH), 5.36 (d, J = 8.1 Hz, 1H, CH), 7.08 (d, JP-H = 726.9 Hz, 1H, P-H), 7.23-7.46 (m, 16H), 
7.56-7.63 (m, 4H). 13C NMR (CDCl3) δ 142.15 (d), 141.65 (d), 137.66 (d), 137.45 (d), 
127.27 (d), 127.00 (d), 126.77 (d), 126.45 (d), 125.95 (d), 125.34 (d), 112.90 (s), 87.31 (s), 
87.14 (s), 78.57 (s), 78.30 (s), 25.28 (s), 24.79 (s). 31P NMR (CDCl3) δ – 4.76 (d). MS (CI+) 
532, 531 (M+1+NH4+), 530 (M+NH4+, 100%), 528, 462, 449, 448, 431, 390, 366, 340, 207, 











General procedure for the synthesis of L3.15, L3.18 (attempted procedure for 
L3.19-L3.21) 
 
Two different methods were used for the attempted synthesis of L3.19-L3.21. One is the 
addition of a Grignard reagent to a PhPCl2 solution at –20 oC (Scheme 3.20). Another one 
is via the use of lithium reagents, which are added to a PhPCl2 solution at –20 oC, as 
illustrated below: 
In a 250 ml 3-necked round flask under N2, was placed 2-methyl pyridine or 
2-bromo-pyridine and dry THF (50 ml). The mixture was cooled to –78 oC and a solution 
of n-BuLi (1.6 M in n-hexane) was slowly added to form a clear red solution. After the 
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addition was complete, the solution was allowed to warm to RT for 2 h. It was then cooled 
and added to the solution of PhPCl2 in 50 ml of THF at –20 oC. The solution was allowed to 
warm up to RT overnight. Water (20 ml) was added at 0 oC, the pH was adjusted to >9 with 
50% aq. NaOH, followed by extraction with EtOAc (3 x 50 ml), washing with brine (3 x 50 
ml) and drying over MgSO4. After removal of the solvent, the residue was purified by flash 
column chromatography (SiO2, EtOAc:Et3N, 90:10). L3.15, L3.18 were isolated as 
side-products in the attempts to synthesize L3.20-L3.21. 
 
2-[Phenyl(2-pyridinyl)phosphino]pyridine (L3.15) and its oxide 3.17 
Prepared from 2-bromo-pyridine (50 mmol, 4.8 ml), Mg turnings (90 mmol, 2.0 g) and 
PhPCl2 (60 mmol, 8 ml). After work-up and removal of the solvent, the 
residue was purified by flash column chromatography (SiO2, EtOAc: 
Et3N, 90:10) to give L3.15  as a light yellow cubic crystals. Isolated yield 
33% (4.4 g, 16.5 mmol). The spectral data were in accordance with the 
literature.  mp 95-97 oC (lit.37 97-98 oC). 1H NMR (CDCl3) δ 7.11-7.26 
(m, 4H), 7.33-7.40 (m, 3H), 7.42-7.60 (m, 4H), 8.67-8.71 (m, 2H). 13C NMR (CDCl3) δ 
161.47, 161.38, 148.92, 148.68, 134.42, 134.35, 134.29, 133.69, 133.44 (d, J = 98.4 Hz), 
133.29, 128.10, 127.35, 127.19, 127.02, 126.67, 120.96. 31P NMR (CDCl3) δ –3.35 (s). MS 
(EI+) 265 (M+1), 264 (M), 263 (M-1), 233, 187, 186, 185 (100 %), 184, 157, 109, 107, 79, 
78, 77, 51. 
N P
N
In the reaction, the oxidized product 3.17 38  was also found and isolated as light 
brown-yellow solid. Isolated yield 12% (1.65 g, 6 mmol). The spectral 
data were in accordance with the literature. 1H NMR (CDCl3) δ 
7.30-7.51 (m, 5H), 7.67-8.00 (m, 2H), 8.01-8.10 (m, 4H), 8.70-8.72 (m, 
2H). 13C NMR (CDCl3) δ 155.57, 152.93, 148.96, 148.57, 134.60, 
134.41, 130.96, 130.77, 130.62, 130.57, 128.63 (d, J = 103.4 Hz), 
126.84, 126.59, 126.42, 123.93, 123.87. 31P NMR (CDCl3) δ 16.72 (s). MS (EI+) 281 






Phenyl[bis(2-pyridinylmethyl)]phosphine oxide (L3.18) 
Prepared from 2-methyl-pyridine (53.8 mmol, 5.3 ml), n-BuLi (1.6 M in n-hexane, 53.8 
mmol, 33.6 ml) and PhPCl2 (54 mmol, 7.3 ml). After work-up and 
removal of the solvent, the residue was purified by flash column 
chromatography (SiO2, EtOAc:Et3N, 90:10) to give L3.18 as a light 
yellow solid. Isolated yield 45% (7.5 g, 24.2 mmol). mp 102-104 oC. 
1H NMR (CDCl3) δ 3.57 (s, 2H, CH2), 3.64 (s, 2H, CH2), 6.95-7.20 
(m, 2H), 7.22-7.56 (m, 9H), 8.34 (d, J = 4.2 Hz, 2H). 13C NMR (CDCl3) δ 151.23, 151.07 








123.29, 120.25, 120.20, 39.52, 38.29. 31P NMR (CDCl3) δ 34.81 (s). MS (EI+) 309 (M+1), 
308 (M, 12.2%), 217, 216 (M-PyCH2, 100%), 184, 169, 168, 167, 93, 92, 78, 65. 
 
tert-Butyl(phenyl)thioxophosphorane (L3.17)23a
A solution of racemic ligand L3.4 (t-BuPhPOH) (0.11 g, 0.6 mmol) and P2S5 (30 mg,  0.14 
mmol) in dry toluene (10 ml) were stirred at RT overnight, filtered and the 
solid was washed with toluene (3 x 10 ml). The solvent was removed to give a 
light yellow oil, which was purified by flash column chromatography [SiO2, 
petroleum ether (40-60 oC):Et2O, 1:1] to provide L3.1723a as a colorless oil 
which solidified in the refrigerator. Isolated yield 62% (73.7 mg, 0.37 mmol). The spectral 
data were in accordance with the literature.23a 1H NMR (CDCl3) δ 0.93 (d, J = 18.1 Hz, 9H, 
3CH3), 6.72 (d, J = 444.6 Hz, 1H, P-H), 7.11-7.39  (m, 3H), 7.42-7.62 (m, 2H). 13C NMR 
(CDCl3) δ 130.55, 130.30, 130.09, 127.38, 127.17 (d, J = 73.6 Hz), 126.78, 32.05 (d, J = 
50.4 Hz), 22.99 (d, J = 3.1 Hz). 31P NMR (CDCl3) δ 51.21 (s). MS (EI+) 199 (M+1), 198 
(M), 176, 143, 142, 141, 109, 108, 107, 91, 79 (100%), 77, 63, 57, 51. HRMS (EI+) M+ for 




Separation of L3.17 on preparative chiral HPLC (Daicel, chiralpak AD column, 250 x 20 
mm i.d.) with different solvents combination was not successful. It could only be separated 
on an analytical HPLC column (Daicel, chiralpak OD column, 250 x 4.6 mm i.d.), flow 
rate 1 ml/min, 220 nm, n-heptane/2-propanol = 99/1, t1 =11.5 min, t2 = 12.8 min. However, 
no preparative OD column for HPLC is available. 
Another route23 starts with (S)-(-)-L3.4 (2 mmol, 0.37 g) and S8 (2.2 mmol, 0.56 g) in 
toluene (5 ml). After filtration and removal of the solvent, the residue 
was purified by flash column chromatography (SiO2, CHCl3:MeOH, 4:1) 
to give 3.1623a as a light yellow solid. Isolated yield 75% (0.32 g, 1.5 
mmol). The spectral data were in accordance with the literature.23a  1H 
NMR (CDCl3) δ 1.05 (d, J = 17.1 Hz, 9H, 3CH3), 5.11 (br, 1H, OH), 
7.35-7.42 (m, 3H), 7.73-7.84 (m, 2H). 31P NMR (CDCl3) δ 84.80 (s). Subsequently, 3.16 
was treated with (CF3SO2)2O (3.5 mmol, 0.6 ml) in dry DCM (10 ml) at –60 oC and the 
solution allowed to warm to RT overnight. CaH2 was added to destroy excess (CF3SO2)2O 
and formed CF3SO2H followed by filtration. Then the residue was dissolved in absolute 
EtOH (5 ml) and added to NaBH4 (3 mmol, 0.11 g) in 10 ml of absolute EtOH at –40 oC. 
The solution was allowed to warm to RT overnight. After filtration and removal of the 
solvent, however, no desired product L3.17 was present according to 31P NMR and 1H 
NMR. The residue was mainly 3.16 accompanied by a by-product with absorption at 97.01 
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